33
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Governance of Stem Cell Research and Its Clinical Translation in China: An Example of Profit-Oriented Bionetworking

&
Pages 397-412 | Received 07 Jan 2015, Accepted 12 Jun 2015, Published online: 01 Oct 2020

References

  • Chen Z. , Wang H.-G. , Wen Z.-J. , and Wang Y. (2007). Life Sciences and Biotechnology in China. Philosophical Transactions of the Royal Society, Series B, Biological Sciences 362: 947–57.
  • China National Center for Biotechnology Development (2011). Notification of the Major Project Topics in the Domain “Stem Cell and Tissue Engineering” of the 11th Five-Year Plan's “863” Program for Biology and Medical Technology (十一五 “863”计划生物和医药技术领域”干细胞与组织工程”重大项目课题验收会的通知) (http://www.research.pku.edu.cn/Article_Show.asp?ArticleID = 1926, accessed 7 August 2015).
  • CURE (2009). Medical Research Council: CURE Committee Report (http://www.mrc.ac.uk/news-events/publications/china-uk-research-ethics-cure-committee-report/, accessed 7 August 2015).
  • Cyranoski D. (2012). Stem-Cell Pioneer Banks on Future Therapies. Nature 488: 139.
  • Gottweis H. (2009). Editorial: Biopolitics in Asia. New Genetics and Society 28, no. 3: 201–4.
  • ISSCR (International Society for Stem Cell Research) (2014). Guidelines for the Clinical Translation of Stem Cells (http://www.isscr.org/home/publications/ClinTransGuide, accessed 7 August 2015).
  • MoH (Ministry of Health) (2012). Notification of the Jiling Guigu Hospital and Jiling High-Tech Hospital's Violations of Laws and Regulations Concerning Stem Cell Clinical Application (关于吉林硅谷医院和吉林高新技术医院违法违规开展干细胞相关活动的通报), 28 December 2012 (http://www.sda.gov.cn/WS01/CL0852/77294.html).
  • MoST (Ministry of Science and Technology) (2013). The Domain of “Stem Cell Therapy Technology and Clinical Translation and Applied Research” of the 12th Five-Year Plan's “863” Program for Biology and Medical Technology (十二五”863”计划生物和医药技术领域”干细胞治疗技术临床转化及应用研究), 16 February 2013 (http://www.most.gov.cn/kjbgz/201302/t20130208_99717.htm).
  • Patra Kumar P. , and Sleeboom-Faulkner M. (2009). Bionetworking: Experimental Stem Cell Therapy and Patient Recruitment in India. Anthropology and Medicine 16, no. 2: 147–63.
  • Rose N. (1999). Powers of Freedom: Reframing Political Thought. Cambridge: Cambridge University Press.
  • Rose N. (2001). The Politics of Life Itself. Theory, Culture and Society 1, no. 6: 1–30.
  • Salter B. (2008). Governing Stem Cell Science in China and India: Emerging Economies and the Global Politics of Innovation. New Genetics and Society 27, no. 2: 145–59.
  • Sleeboom-Faulkner M. (2011). Looking beyond the Regulatory Exteriors of Stem Cell Research in Asia—Discussion. New Genetics and Society 30, no. 3: 279–88.
  • Sleeboom-Faulkner M. (2013). Latent Science Collaboration: Strategic Cultures of Bioethical Capacity Building in Mainland China's Stem Cell World. Biosocieties 8, no. 32: 7–24.
  • Sleeboom-Faulkner M. , and Kumar Patra P. (2011). Experimental Stem Cell Therapy: Biohierarchies and Bionetworking in Japan and India. Social Studies of Science 41, no. 5: 696–707.
  • Wahlberg A. , Rehmann-Sutter C. , Sleeboom-Faulkner M. , Lu G. X. , Döring O. , Cong Y. L. , Laska-Formejster A. , He J. , Chen H. D. , Gottweis H. , and Rose N. (2013). From Global Bioethics to Ethical Governance of Biomedical Research Collaborations. Social Science and Medicine 98: 293–300.
  • Wang J. (2011). Establishing the National Stem Cell Leadership and Coordination Committee. http://ScienceNet.cn , 21 October 2011 (http://news.sciencenet.cn/htmlnews/2011/10/254182.shtm).
  • Yang Y. T. (2011). The Spring of Stem Cell and Regenerative Medicine. China Economic Net, 20 June 2011 (http://www.stemcells.com.cn/ohter/HTML/ohter_20110620115058.html).
  • Zhang X. Q. , and Sleeboom-Faulkner M. (2011). Tensions between Medical Professionals and Patients in Mainland China: Issues of Communication, Trust and Medical Provisions. Cambridge Quarterly of Healthcare Ethics 20, no. 3: 458–67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.